RNA Binding Proteins: From Structure to Inhibitors
August 10 – 14, 2025 | Niagara Falls, New York
This inaugural conference will explore the latest developments in RNA-binding protein druggability. The program will explore the structural intricacies of RBPs, explaining how their conformations influence RNA interactions and function. The conference will also cover the latest advancements in inhibitor development for targeting these proteins, highlighting their potential as therapeutic agents in treating diseases, focusing on cancer pathologies.
Attendees will gain a comprehensive understanding of the molecular mechanisms underpinning RNA-protein interactions. They will also learn about the innovative strategies employed to modulate these pathways for therapeutic benefit, mainly in the cancer area.
